{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:30:29Z","timestamp":1790368229070,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"lma Mater Studiorum \u2013 University of Bologna (Fundamental Oriented Research, RFO funds), B"},{"name":"ologna Local Healthcare Service and Italian Institute of Technology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpba.2020.113384","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:44:34Z","timestamp":1590183874000},"page":"113384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs"],"prefix":"10.1016","volume":"188","author":[{"given":"Camilla","family":"Marasca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mandrioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"De Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113384_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5)","year":"2013"},{"key":"10.1016\/j.jpba.2020.113384_bib0010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1037\/abn0000362","article-title":"WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders","volume":"127","author":"Auerbach","year":"2018","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jpba.2020.113384_bib0015","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2174\/092986712800099749","article-title":"Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions","volume":"19","author":"Mandrioli","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113384_bib0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/0929867324666170712165042","article-title":"New-generation, non-SSRI antidepressants: therapeutic drug monitoring and pharmacological interactions. Part 1: SNRIs, SMSs, SARIs","volume":"25","author":"Mandrioli","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113384_bib0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/092986712803414277","article-title":"Emerging targets for the pharmacological treatment of depression: focus on melatonergic system","volume":"19","author":"Catena-Dell\u2019Osso","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113384_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/0929867013373796","article-title":"Current trends in the development of new antidepressants","volume":"8","author":"Pacher","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113384_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jssc.200900493","article-title":"Simultaneous HPLC determination of fourteen tricyclic antidepressants and metabolites in human plasma","volume":"33","author":"Mercolini","year":"2010","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113384_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpba.2020.113384_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jchromb.2010.11.033","article-title":"Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV for therapeutic drug monitoring purposes","volume":"879","author":"Mandrioli","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113384_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1389200216666150602145005","article-title":"Novel atypical antipsychotics: metabolism and therapeutic drug monitoring (TDM)","volume":"16","author":"Mandrioli","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2020.113384_bib0055","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.4155\/bio.14.3","article-title":"Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients","volume":"6","author":"Mercolini","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2020.113384_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chroma.2012.11.030","article-title":"Dried blood spots: liquid chromatography-mass spectrometry analysis of \u03949-tetrahydrocannabinol and its main metabolites","volume":"1271","author":"Mercolini","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113384_bib0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aca.2018.09.004","article-title":"Tutorial: volumetric absorptive microsampling (VAMS)","volume":"1046","author":"Mercolini","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113384_bib0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and clinical toxicology guideline: development and validation of dried blood spot\u2013based methods for therapeutic drug monitoring","volume":"41","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2020.113384_bib0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1389200043335379","article-title":"Methods to assess tissue-specific distribution and metabolism of drugs","volume":"5","author":"Langer","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2020.113384_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.aca.2011.05.037","article-title":"Microextraction by packed sorbent (MEPS): a tutorial","volume":"701","author":"Abdel-Rehim","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113384_bib0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1556\/1326.2017.29.3.02","article-title":"Determination of vortioxetine in human serum and saliva samples by HPLC-DAD and HPLC-MS","volume":"29","author":"Wr\u00f3blewski","year":"2017","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jpba.2020.113384_bib0090","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.4155\/bio.15.207","article-title":"Quantitative determination of the antidepressant vortioxetine and its major human metabolite in plasma","volume":"7","author":"Kall","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2020.113384_bib0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpba.2019.03.065","article-title":"A clinical study for the evaluation of pharmacokinetic interaction between daclatasvir and fluoxetine","volume":"17","author":"Oraby","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113384_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2006.03.026","article-title":"HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma","volume":"836","author":"Mandrioli","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113384_bib0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchromb.2016.10.023","article-title":"Determination of clozapine, and five antidepressants in human plasma, serum and whole blood by gas chromatography\u2013mass spectrometry: a simple tool for clinical and postmortem toxicological analysis","volume":"1038","author":"Boumba","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113384_bib0110","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1002\/jssc.201600952","article-title":"Dispersive liquid\u2013liquid microextraction combined with acetonitrile stacking through capillary electrophoresis for the determination of three selective serotonin reuptake inhibitor drugs in body fluids","volume":"39","author":"Lin","year":"2016","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2020.113384_bib0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpba.2016.01.004","article-title":"Determination of some psychotropic drugs in serum and saliva samples by HPLC-DAD and HPLC MS","volume":"127","author":"Petruczynik","year":"2016","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113384_bib0120","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1021\/acs.analchem.9b01637","article-title":"Quantitative swab touch spray mass spectrometry for oral fluid drug testing","volume":"91","author":"Morato","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2020.113384_bib0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.aca.2017.05.033","article-title":"Dried urine spots - a novel sampling technique for comprehensive LC-MSn drug screening","volume":"982","author":"Michely","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2020.113384_bib0130","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures: Text and methodology Q2(R1) (2015). https:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf (accessed 10 February 2020)."},{"key":"10.1016\/j.jpba.2020.113384_bib0135","first-page":"307","article-title":"Distribution of antidepressants between plasma and red blood cells","volume":"27","author":"Fi\u0161ar","year":"2006","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.jpba.2020.113384_bib0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0009-9120(97)00101-X","article-title":"Analysis of sertraline and desmethylsertraline in human plasma and red blood cell","volume":"30","author":"Vatassery","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2020.113384_bib0145","first-page":"134","article-title":"Red cell and plasma concentrations of fluoxetine and norfluoxetine","volume":"35","author":"Amitai","year":"1993","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.jpba.2020.113384_bib0150","first-page":"1115","article-title":"Effect of food on the pharmacokinetics of Lu AA21004 in healthy volunteers","volume":"49","author":"Wang","year":"2009","journal-title":"J. Clin. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852031270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170852031270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:03:02Z","timestamp":1760000582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170852031270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S073170852031270X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113384","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113384"}}